Company profile: Alsachim
1.1 - Company Overview
Company description
- Provider of contract research and development services to customers around the world, stable isotope-labeled compounds for pharmaceuticals, environmental studies, and clinical diagnostics, and labeled internal and reference standards for LC-MS/MS analysis to ensure accurate quantification.
Products and services
- Contract Research and Development Services: Alsachim delivers global-scale contract research and development services to customers around the world as a provider of contract R&D
- LC-MS/MS Analysis Standards: Alsachim supplies LC-MS/MS-specific labeled internal standards and reference standards for LC-MS/MS analysis to ensure accurate quantification of compounds
- Stable Isotope-Labeled Compounds: Alsachim produces application-specific stable isotope-labeled compounds for various applications, including pharmaceuticals, environmental studies, and clinical diagnostics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alsachim
HiFiBiO Therapeutics
HQ: France
Website
- Description: Provider of proprietary single-cell technologies for drug and biomarker discovery and development, and biotherapeutic antibody candidates that mobilize the immune system, including targets TNFR2, OX-40, BTLA, Gal-9, CCR8, and CXCR5 for solid tumors, myeloid malignancies, B cell lymphomas, and autoimmune diseases; collaborates through open-innovation partnerships with industry and academia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HiFiBiO Therapeutics company profile →
Standard BioTools
HQ: United States
Website
- Description: Provider of microfluidic-based chips and instrumentation for biological research as a biotech tools company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Standard BioTools company profile →
Surmodics
HQ: United States
Website
- Description: Provider of surface modification and in vitro diagnostic technologies to the healthcare industry, and developer and commercializer of highly differentiated vascular intervention medical devices designed to address unmet clinical needs and engineered to the most demanding requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surmodics company profile →
PharmaFluidics
HQ: Belgium
Website
- Description: Provider of integrated milli- to nano-engineered solutions for mixing, separation and reaction processes, offering high-quality, tailor-made designs. Products include μPAC Neo silicon-based HPLC columns for high-resolution separations; EASY-Spray and Double nanoViper columns for nano/capillary LC-MS and robust proteomics; MAbPac RP for intact protein characterization; Accucore 150 Amide HILIC for hydrophilic biomolecules/glycans.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaFluidics company profile →
BioSeek
HQ: United States
Website
- Description: Provider of cell-based human disease models for drug discovery and development, offering BioMap Systems—human primary cell-based assay systems for indications in vascular inflammation, cardiovascular and respiratory diseases, and fibrosis—and programs for the discovery of lead compounds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioSeek company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alsachim
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alsachim
2.2 - Growth funds investing in similar companies to Alsachim
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alsachim
4.2 - Public trading comparable groups for Alsachim
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →